Analyze Diet
BMC cardiovascular disorders2019; 19(1); 228; doi: 10.1186/s12872-019-1210-4

Longitudinal study of electrical, functional and structural remodelling in an equine model of atrial fibrillation.

Abstract: Large animal models are important in atrial fibrillation (AF) research, as they can be used to study the pathophysiology of AF and new therapeutic approaches. Unlike other animal models, horses spontaneously develop AF and could therefore serve as a bona fide model in AF research. We therefore aimed to study the electrical, functional and structural remodelling caused by chronic AF in a horse model. Nine female horses were included in the study, with six horses tachypaced into self-sustained AF and three that served as a time-matched sham-operated control group. Acceleration in atrial fibrillatory rate (AFR), changes in electrocardiographic and echocardiographic variables and response to medical treatment (flecainide 2 mg/kg) were recorded over a period of 2 months. At the end of the study, changes in ion channel expression and fibrosis were measured and compared between the two groups. AFR increased from 299 ± 33 fibrillations per minute (fpm) to 376 ± 12 fpm (p < 0.05) and atrial function (active left atrial fractional area change) decreased significantly during the study (p < 0.05). No changes were observed in heart rate or ventricular function. The AF group had more atrial fibrosis compared to the control group (p < 0.05). No differences in ion channel expression were observed. Horses with induced AF show signs of atrial remodelling that are similar to humans and other animal models.
Publication Date: 2019-10-21 PubMed ID: 31638896PubMed Central: PMC6805623DOI: 10.1186/s12872-019-1210-4Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research paper investigates the changes in heart structure, function, and electrical activities in horses that suffer from chronic atrial fibrillation (AF). The study’s findings suggest that horses with artificially induced AF show signs of atrial remodeling similar to humans and other animal models.

Understanding the Study

  • The main objective of this research was to explore the structural, functional, and electrical changes caused by chronic AF in horses. The reason for using horses as a subject for this study is that they often develop AF naturally, making them a potentially valid model for studying this heart condition.
  • The scientists involved in this research used a total of nine female horses. Six of these horses were put into a state of self-supported AF through tachypacing – a technique whereby the heart rate is artificially increased. The remaining three horses comprise the control group, subjected to sham operations that mimic the actual procedure but without its true effect, ensuring comparison between normal and affected conditions.
  • The researchers used various methods to track the progression of this heart condition in the horses. They monitored changes in the heart rate of fibrillations, observed shifts in electrocardiographic and echocardiographic variables, and studied the responses to a specific medical treatment (flecainide). All these records were noted over a timeframe of two months.

Key Findings

  • The measure of the atrial fibrillatory rate (AFR) rose significantly during the study period – from 299±33 fibrillations per minute (fpm) to 376±12 fpm. The study confirmed that the rate of fibrillations increases with time in the case of chronic AF.
  • There was a significant decrease in active left atrial fractional area change, suggesting a reduction in atrial function during the experiment.
  • No changes were observed in either heart rate or the performance of the ventricles, implying that effects of AF are primarily confined to atria.
  • The AF group had more cases of atrial fibrosis (tissue thickening and scarring in the atrium) compared to the control group, pointing to structural changes being part of AF’s influence.
  • The scientists observed no changes in ion channel expression between the two groups of horses, indicating that this aspect may be less influenced by chronic AF.
  • Importantly, the study found that induced AF in horses shows remodeling patterns in the heart that are similar to humans and other animal models, endorsing the validity of horses as a reliable model for studying AF.

Implications of the Research

  • This study validates the role of horses in AF research, as the impact of AF on their hearts reflects the progression of this condition in humans. The findings, therefore, could be applied to improve our understanding of AF and its management in humans.
  • The study highlights the importance of large animal models in AF research, providing a more realistic basis for studying the pathophysiology of this cardiac condition and evaluating the effectiveness of therapeutic interventions.
  • The findings also point towards the potential structural and functional changes that AF may induce in the afflicted heart, furthering our understanding of AF’s impact on cardiac health.

Cite This Article

APA
Hesselkilde EZ, Carstensen H, Flethøj M, Fenner M, Kruse DD, Sattler SM, Tfelt-Hansen J, Pehrson S, Braunstein TH, Carlson J, Platonov PG, Jespersen T, Buhl R. (2019). Longitudinal study of electrical, functional and structural remodelling in an equine model of atrial fibrillation. BMC Cardiovasc Disord, 19(1), 228. https://doi.org/10.1186/s12872-019-1210-4

Publication

ISSN: 1471-2261
NlmUniqueID: 100968539
Country: England
Language: English
Volume: 19
Issue: 1
Pages: 228

Researcher Affiliations

Hesselkilde, Eva Zander
  • Department of Veterinary Clinical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Højbakkegaard Allé 5, 2630, Taastrup, Denmark.
Carstensen, Helena
  • Department of Veterinary Clinical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Højbakkegaard Allé 5, 2630, Taastrup, Denmark.
Flethøj, Mette
  • Department of Veterinary Clinical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Højbakkegaard Allé 5, 2630, Taastrup, Denmark.
Fenner, Merle
  • Department of Veterinary Clinical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Højbakkegaard Allé 5, 2630, Taastrup, Denmark.
Kruse, Ditte Dybvald
  • Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3, 2200, Copenhagen, Denmark.
Sattler, Stefan M
  • Department of Cardiology, The Heart Centre, Copenhagen University Hospital, Blegdamsvej 9, 2100, Copenhagen, Denmark.
  • Department of Medicine I, University Hospital Munich, Campus Grosshadern, Ludwig-Maximilians University Munich (LMU), Munich, Germany.
Tfelt-Hansen, Jacob
  • Department of Cardiology, The Heart Centre, Copenhagen University Hospital, Blegdamsvej 9, 2100, Copenhagen, Denmark.
  • Department of Forensic Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Frederik V's vej 11, 2100, Copenhagen, Denmark.
Pehrson, Steen
  • Department of Cardiology, The Heart Centre, Copenhagen University Hospital, Blegdamsvej 9, 2100, Copenhagen, Denmark.
Braunstein, Thomas Hartig
  • Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3, 2200, Copenhagen, Denmark.
Carlson, Jonas
  • Department of Cardiology, Clinical Sciences, Arrhythmia Clinic, Skåne University Hospital, Lund University, 21185, Lund, Sweden.
Platonov, Pyotr G
  • Department of Cardiology, Clinical Sciences, Arrhythmia Clinic, Skåne University Hospital, Lund University, 21185, Lund, Sweden.
Jespersen, Thomas
  • Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3, 2200, Copenhagen, Denmark.
Buhl, Rikke
  • Department of Veterinary Clinical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Højbakkegaard Allé 5, 2630, Taastrup, Denmark. rib@sund.ku.dk.

MeSH Terms

  • Action Potentials / drug effects
  • Animals
  • Anti-Arrhythmia Agents / pharmacology
  • Atrial Fibrillation / drug therapy
  • Atrial Fibrillation / etiology
  • Atrial Fibrillation / metabolism
  • Atrial Fibrillation / physiopathology
  • Atrial Function, Left / drug effects
  • Atrial Remodeling / drug effects
  • Cardiac Pacing, Artificial
  • Disease Models, Animal
  • Female
  • Fibrosis
  • Flecainide / pharmacology
  • Heart Atria / drug effects
  • Heart Atria / metabolism
  • Heart Atria / physiopathology
  • Heart Rate / drug effects
  • Horses
  • Ion Channels / metabolism
  • Time Factors

Conflict of Interest Statement

The authors declare that they have no competing interests.

References

This article includes 44 references
  1. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2014;64(21):e1–76.
    doi: 10.1016/j.jacc.2014.03.022pubmed: 24685669google scholar: lookup
  2. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995;92(7):1954–1968.
    doi: 10.1161/01.CIR.92.7.1954pubmed: 7671380google scholar: lookup
  3. Nishida K, Michael G, Dobrev D, Nattel S. Animal models for atrial fibrillation: clinical insights and scientific opportunities. Europace 2010;12(2):160–172.
    doi: 10.1093/europace/eup328pubmed: 19875395google scholar: lookup
  4. Haugaard MM, Hesselkilde EZ, Pehrson S, Carstensen H, Flethoj M, Praestegaard KF. Pharmacologic inhibition of small-conductance calcium-activated potassium (SK) channels by NS8593 reveals atrial antiarrhythmic potential in horses. Heart rhythm : the official journal of the Heart Rhythm Society 2015;12(4):825–835.
    doi: 10.1016/j.hrthm.2014.12.028pubmed: 25542425google scholar: lookup
  5. Carstensen H, Kjaer L, Haugaard MM, Flethoj M, Hesselkilde EZ, Kanters JK. Antiarrhythmic effects of combining Dofetilide and Ranolazine in a model of acutely induced atrial fibrillation in horses. J Cardiovasc Pharmacol 2018;71(1):26–35.
  6. Decloedt A, Schwarzwald CC, De Clercq D, Van Der Vekens N, Pardon B, Reef VB. Risk factors for recurrence of atrial fibrillation in horses after cardioversion to sinus rhythm. Journal of veterinary internal medicine / American College of Veterinary Internal Medicine 2015;29(3):946–953.
    doi: 10.1111/jvim.12606pmc: PMC4895430pubmed: 25917409google scholar: lookup
  7. Haugaard MM, Pehrson S, Carstensen H, Flethoj M, Hesselkilde EZ, Praestegaard KF. Antiarrhythmic and electrophysiologic effects of flecainide on acutely induced atrial fibrillation in healthy horses. Journal of veterinary internal medicine / American College of Veterinary Internal Medicine 2015;29(1):339–347.
    doi: 10.1111/jvim.12496pmc: PMC4858114pubmed: 25328012google scholar: lookup
  8. De Clercq D, van Loon G, Tavernier R, Duchateau L, Deprez P. Atrial and ventricular electrical and contractile remodeling and reverse remodeling owing to short-term pacing-induced atrial fibrillation in horses. Journal of veterinary internal medicine / American College of Veterinary Internal Medicine 2008;22(6):1353–1359.
  9. Van Loon G, Duytschaever M, Tavernier R, Fonteyne W, Jordaens L, Deprez P. An equine model of chronic atrial fibrillation: methodology. Veterinary journal (London, England : 1997) 2002;164(2):142–50.
    pubmed: 12359469
  10. De Clercq D, van Loon G, Tavernier R, Verbesselt R, Deprez P. Use of propafenone for conversion of chronic atrial fibrillation in horses. Am J Vet Res 2009;70(2):223–227.
    doi: 10.2460/ajvr.70.2.223pubmed: 19231955google scholar: lookup
  11. Van Loon G, Tavernier R, Duytschaever M, Fonteyne W, Deprez P, Jordaens L. Pacing induced sustained atrial fibrillation in a pony. Canadian Journal of Veterinary Research-Revue Canadienne De Recherche Veterinaire 2000;64(4):254–258.
    pmc: PMC1189629pubmed: 11041507
  12. Van Loon G, Fonteyne W, Rottiers H, Tavernier R, Jordaens L, D'Hont L. Dual-chamber pacemaker implantation via the cephalic vein in healthy equids. Journal of veterinary internal medicine / American College of Veterinary Internal Medicine 2001;15(6):564–571.
  13. Carstensen H, Hesselkilde EZ, Fenner M, Loft-Andersen AV, Flethoj M, Kanters JK. Time-dependent antiarrhythmic effects of flecainide on induced atrial fibrillation in horses. Journal of veterinary internal medicine / American College of Veterinary Internal Medicine 2018;32(5):1708–1717.
    doi: 10.1111/jvim.15287pmc: PMC6189357pubmed: 30133839google scholar: lookup
  14. Pedersen PJ, Kanters JK, Buhl R, Klaerke DA. Normal electrocardiographic QT interval in race-fit Standardbred horses at rest and its rate dependence during exercise. Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology 2013;15(1):23–31.
    doi: 10.1016/j.jvc.2012.08.002pubmed: 23434174google scholar: lookup
  15. Platonov PG, Corino VDA, Seifert M, Holmqvist F, Sornmo L. Atrial fibrillatory rate in the clinical context: natural course and prediction of intervention outcome. Europace 2014;16(suppl 4):iv110–iv119.
    doi: 10.1093/europace/euu249pubmed: 25362161google scholar: lookup
  16. Stridh M, Sornmo L. Spatiotemporal QRST cancellation techniques for analysis of atrial fibrillation. IEEE Trans Biomed Eng 2001;48(1):105–111.
    doi: 10.1109/10.900266pubmed: 11235581google scholar: lookup
  17. Flethoj M, Schwarzwald CC, Haugaard MM, Carstensen H, Kanters JK, Olsen LH. Left ventricular function after prolonged exercise in equine endurance athletes. Journal of veterinary internal medicine / American College of Veterinary Internal Medicine 2016;30(4):1260–1269.
    doi: 10.1111/jvim.13982pmc: PMC5094507pubmed: 27305095google scholar: lookup
  18. Schwarzwald CC, Schober KE, Bonagura JD. Echocardiographic evidence of left atrial mechanical dysfunction after conversion of atrial fibrillation to sinus rhythm in 5 horses. Journal of veterinary internal medicine / American College of Veterinary Internal Medicine 2007;21(4):820–827.
  19. Reef VB, Bain FT, Spencer PA. Severe mitral regurgitation in horses: clinical, echocardiographic and pathological findings. Equine Vet J 1998;30(1):18–27.
  20. Dosdall DJ, Ranjan R, Higuchi K, Kholmovski E, Angel N, Li L. Chronic atrial fibrillation causes left ventricular dysfunction in dogs but not goats: experience with dogs, goats, and pigs. Am J Physiol Heart Circ Physiol 2013;305(5):H725–H731.
    doi: 10.1152/ajpheart.00440.2013pmc: PMC4116536pubmed: 23812387google scholar: lookup
  21. Daoud EG, Bogun F, Goyal R, Harvey M, Man KC, Strickberger SA. Effect of atrial fibrillation on atrial refractoriness in humans. Circulation 1996;94(7):1600–1606.
    doi: 10.1161/01.CIR.94.7.1600pubmed: 8840850google scholar: lookup
  22. Morillo CA, Klein GJ, Jones DL, Guiraudon CM. Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation 1995;91(5):1588–1595.
    doi: 10.1161/01.CIR.91.5.1588pubmed: 7867201google scholar: lookup
  23. Rahme MM, Cotter B, Leistad E, Subudhayangkul S, Wadhwa M, Ungab G. Persistence of atrial fibrillation after its induction-importance of the duration and dispersion of atrial refractoriness and electrical remodeling. J Cardiovasc Pharmacol Ther 1999;4(2):113–120.
    doi: 10.1177/107424849900400206pubmed: 10684530google scholar: lookup
  24. Holm M, Pehrson S, Ingemansson M, Sornmo L, Johansson R, Sandhall L. Non-invasive assessment of the atrial cycle length during atrial fibrillation in man: introducing, validating and illustrating a new ECG method. Cardiovasc Res 1998;38(1):69–81.
    doi: 10.1016/S0008-6363(97)00289-7pubmed: 9683908google scholar: lookup
  25. Bollmann A, Kanuru NK, McTeague KK, Walter PF, DeLurgio DB, Langberg JJ. Frequency analysis of human atrial fibrillation using the surface electrocardiogram and its response to ibutilide. Am J Cardiol 1998;81(12):1439–1445.
    doi: 10.1016/S0002-9149(98)00210-0pubmed: 9645894google scholar: lookup
  26. Hesselkilde EZ, Carstensen H, Haugaard MM, Carlson J, Pehrson S, Jespersen T. Effect of flecainide on atrial fibrillatory rate in a large animal model with induced atrial fibrillation. BMC Cardiovasc Disord 2017;17(1):289.
    doi: 10.1186/s12872-017-0720-1pmc: PMC5723027pubmed: 29221440google scholar: lookup
  27. Platonov PG, Stridh M, de Melis M, Urban L, Carlson J, Corbucci G. Analysis of atrial fibrillatory rate during spontaneous episodes of atrial fibrillation in humans using implantable loop recorder electrocardiogram. J Electrocardiol 2012;45(6):723–726.
  28. Yue L, Melnyk P, Gaspo R, Wang Z, Nattel S. Molecular mechanisms underlying ionic remodeling in a dog model of atrial fibrillation. Circ Res 1999;84(7):776–784.
    doi: 10.1161/01.RES.84.7.776pubmed: 10205145google scholar: lookup
  29. Van Wagoner DR, Pond AL, McCarthy PM, Trimmer JS, Nerbonne JM. Outward K+ current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation. Circ Res 1997;80(6):772–781.
    doi: 10.1161/01.RES.80.6.772pubmed: 9168779google scholar: lookup
  30. Allessie M, Ausma J, Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res 2002;54(2):230–246.
    doi: 10.1016/S0008-6363(02)00258-4pubmed: 12062329google scholar: lookup
  31. Khan IA. Atrial stunning: basics and clinical considerations. Int J Cardiol 2003;92(2–3):113–128.
    doi: 10.1016/S0167-5273(03)00107-4pubmed: 14659842google scholar: lookup
  32. Schotten U, Duytschaever M, Ausma J, Eijsbouts S, Neuberger HR, Allessie M. Electrical and contractile remodeling during the first days of atrial fibrillation go hand in hand. Circulation 2003;107(10):1433–1439.
  33. Van Loon G. Atrial pacing and experimental atrial fibrillation in equines. Merelbeke (Beligum): Ghent University; 2001.
  34. Wijesurendra RS, Casadei B. Atrial fibrillation: effects beyond the atrium?. Cardiovasc Res 2015;105(3):238–247.
    doi: 10.1093/cvr/cvv001pmc: PMC4339707pubmed: 25587048google scholar: lookup
  35. Reef VB, Bonagura J, Buhl R, McGurrin MK, Schwarzwald CC, van Loon G. Recommendations for management of equine athletes with cardiovascular abnormalities. Journal of veterinary internal medicine / American College of Veterinary Internal Medicine 2014;28(3):749–761.
    doi: 10.1111/jvim.12340pmc: PMC4895474pubmed: 24628586google scholar: lookup
  36. Reef VB, Levitan CW, Spencer PA. Factors affecting prognosis and conversion in equine atrial fibrillation. Journal of veterinary internal medicine / American College of Veterinary Internal Medicine 1988;2(1):1–6.
  37. Borgeat A, Goy JJ, Maendly R, Kaufmann U, Grbic M, Sigwart U. Flecainide versus quinidine for conversion of atrial fibrillation to sinus rhythm. Am J Cardiol 1986;58(6):496–498.
    doi: 10.1016/0002-9149(86)90022-6pubmed: 3529911google scholar: lookup
  38. Platonov PG. Atrial fibrosis: an obligatory component of arrhythmia mechanisms in atrial fibrillation?. Journal of geriatric cardiology : JGC 2017;14(4):233–237.
    pmc: PMC5483591pubmed: 28663760
  39. Li Y, Jian Z, Yang ZY, Chen L, Wang XF, Ma RY. Increased expression of connective tissue growth factor and transforming growth factor-beta-1 in atrial myocardium of patients with chronic atrial fibrillation. Cardiology 2013;124(4):233–240.
    doi: 10.1159/000347126pubmed: 23571482google scholar: lookup
  40. Dzeshka MS, Lip GY, Snezhitskiy V, Shantsila E. Cardiac fibrosis in patients with atrial fibrillation: mechanisms and clinical implications. J Am Coll Cardiol 2015;66(8):943–959.
    doi: 10.1016/j.jacc.2015.06.1313pubmed: 26293766google scholar: lookup
  41. Cosgrave J, Foley JB, Flavin R, O'Briain DS, Fitzpatrick E, Bennett K. Preoperative atrial histological changes are not associated with postoperative atrial fibrillation. Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology 2006;15(4):213–217.
    doi: 10.1016/j.carpath.2006.04.002pubmed: 16844552google scholar: lookup
  42. Swartz MF, Fink GW, Lutz CJ, Taffet SM, Berenfeld O, Vikstrom KL. Left versus right atrial difference in dominant frequency, K(+) channel transcripts, and fibrosis in patients developing atrial fibrillation after cardiac surgery. Heart rhythm : the official journal of the Heart Rhythm Society 2009;6(10):1415–1422.
    doi: 10.1016/j.hrthm.2009.06.018pmc: PMC2790556pubmed: 19656731google scholar: lookup
  43. Swartz MF, Fink GW, Sarwar MF, Hicks GL, Yu Y, Hu R. Elevated pre-operative serum peptides for collagen I and III synthesis result in post-surgical atrial fibrillation. J Am Coll Cardiol 2012;60(18):1799–1806.
    doi: 10.1016/j.jacc.2012.06.048pmc: PMC3482337pubmed: 23040566google scholar: lookup
  44. Laredo M, Waldmann V, Khairy P, Nattel S. Age as a critical determinant of atrial fibrillation: a two-sided relationship. The Canadian journal of cardiology 2018;34(11):1396–1406.
    doi: 10.1016/j.cjca.2018.08.007pubmed: 30404745google scholar: lookup